Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35902191.
- Also identified by DOI 10.1136/bmjopen-2021-059149 and PMC identifier 9341182.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate the independent and collective impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis (TB). This was a retrospective cohort study. Shandong, China. Patients with newly diagnosed TB from 1 January 2004 to 31 December 2020 were collected. Exclusive criteria: retreated cases; extrapulmonary tuberculosis; without information on drug susceptibility testing results, smoking or drinking habits; bacteriological identification as <i>non-tuberculous mycobacteria</i>. Patients were classified into four groups including smokers only (G<sub>1</sub>), drinker only (G<sub>2</sub>), smoker +drinker (G<sub>3</sub>), non-smoker +non-drinker group (G<sub>0</sub>). We described the drug-resistant profiles, clinical factors and calculated the ORs of different drug-resistance among G<sub>1</sub>, G<sub>2</sub>, G<sub>3</sub>, compared with G<sub>0</sub> through univariate and multivariate logistics regression models. Of the 7996 TB cases enrolled, the proportions of G<sub>1</sub>, G<sub>2</sub>, G<sub>3</sub> and G<sub>0</sub> were 8.25%, 3.89%, 16.46% and 71.40%, respectively. The rates of drug-resistant (DR)-TB, mono-resistant TB, multidrug resistant (MDR)-TB, polydrug resistant TB in G<sub>1,</sub> G<sub>2</sub>, G<sub>3</sub> and G<sub>0</sub> were 19.24%/16.4%/17.33%/19.08%, 11.52%/8.68%/10.94%/11.63%, 3.03%/2.57%/2.96%/3.66% and 4.70%/4.82%/3.34%/ 4.08%, respectively. G<sub>3</sub> had a higher risk of MDR1: isoniazid +rifampin (adjusted OR (aOR)=1.91, 95% CI: 1.036 to 3.532), but had a lower risk of DR-TB (aOR=0.84, 95% CI: 0.71 to 0.99), rifampin-related resistance (aOR=0.68, 95% CI: 0.49 to 0.93), streptomycin-related resistance (aOR=0.82, 95% CI: 0.68 to 0.99), ethambutol-related resistance (aOR=0.57, 95% CI: 0.34 to 0.95), MDR3: isoniazid +rifampin+streptomycin (aOR=0.41, 95% CI: 0.19 to 0.85), any isoniazid +streptomycin resistance (aOR=0.85, 95% CI: 0.71 to 1.00). However, there were no significant differences between G<sub>1</sub> and G<sub>0</sub>, G<sub>2</sub> and G<sub>0</sub> in all drug-resistant subtypes. Those patients with cavity had a higher risk of DR-TB among G<sub>3</sub> (OR=1.35, 95% CI: 1.01 to 1.81). Although we did not found an independent impact of alcohol drinking or tobacco smoking on TB drug-resistance, respectively, these two habits had a combined effect on TB drug-resistance.
Medical subject headings
- Mycobacterium tuberculosis
- Tuberculosis
- Tuberculosis, Multidrug-Resistant